Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

ConclusionsOur findings, using the largest gene panel for MBC patients so far, indicate thatBRCA testing should be the primary concern for MBC patients. Until sufficient evidence arises from larger studies, multiple-gene panels may be of limited benefit for MBC and their families, at least for MBC patients of specific descent.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research